Dahan Michel
- SEC CIK
- 0001669737
No open-market purchases or sales filed in the past year.
Current role at each company
- AKBA Akebia Therapeutics, Inc.SVP, Chief Operating Officeras of May 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dahan Michel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 (view filing) | May 13 | 1 day | Dahan MichelSVP, Chief Operating Officer | SSale | −34.8K | $1.26 | −$43.9K | −4.9%672.1K after | 10b5-1 |
| Mar 1, 2024 (view filing) | Feb 29 | 1 day | Dahan MichelSVP, Chief Operating Officer | SSale | −8.66K | $1.58 | −$13.7K | −1.2%706.9K after | |
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Dahan MichelSVP, Chief Operating Officer | SSale | −10.7K | $1.52 | −$16.3K | −1.5%715.6K after | |
| May 25, 2023 (view filing) | May 25 | Same day | Dahan MichelSVP, Chief Operating Officer | SSale | −95.5K | $1.22 | −$116.5K | −14.3%574.0K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Dahan MichelSVP, Chief Operating Officer | SSale | −20.4K | $0.88 | −$18.0K | −7.0%269.5K after | 3 lots |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Dahan MichelSVP, Chief Operating Officer | SSale | −10.1K | $0.81 | −$8.17K | −3.4%289.9K after | |
| Mar 2, 2022 (view filing) | Feb 28-Mar 1 | 2 days | Dahan MichelSVP, Chief Operating Officer | SSale | −21.5K | $2.16 | −$46.6K | −6.8%297.0K after | 4 lots |